
Flavetag 35mg Tablet SR
Marketer
Ikon Remedies Pvt Ltd
Salt Composition
Trimetazidine (35mg)
Overview Flavetag 35mg Tablet SR
Cardiogard 35mg Extended-Release Tablets are prescribed for angina pectoris, a type of chest pain stemming from heart conditions. This medication acts as a preventative measure against future angina episodes; however, it's ineffective in alleviating an attack already in progress. It may be administered independently or alongside other cardiac medications, as determined by your physician. Consistent daily use, as directed, is crucial. Cardiogard 35mg ER Tablets can be taken with or without food, maintaining a consistent schedule. Dosage frequency is subject to adjustment based on treatment efficacy. Continuous use, even during symptom-free periods, maximizes preventative benefits and reduces the risk of recurrence. Discontinuing treatment may lead to a return of chest pain. Adopting a healthier lifestyle – including smoking cessation, moderate alcohol consumption, a balanced diet, regular physical activity, and stress management – complements the medication's effects. Potential side effects include, but are not limited to, vertigo, cephalalgia, gastrointestinal discomfort (including diarrhea, dyspepsia, nausea, and vomiting), dermatological reactions (rash, pruritus, urticaria), and asthenia. Report any persistent or bothersome side effects to your doctor. Prior to commencing treatment, inform your physician of any pre-existing liver or kidney conditions, pregnancy, breastfeeding, or concurrent medication use.
Uses of Flavetag 35mg Tablet SR
Managing chest pain associated with angina pectoris
Major Benefits of Flavetag 35mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. The Flavetag 35mg Sustained-Release Tablet should be taken with a meal.
Common Side effects of Flavetag 35mg Tablet SR:
- Dizziness
- Headache
- Nausea
- Vomiting
- Weakness
- Rash
- Abdominal pain
- Indigestion
- Itching
- Diarrhea
- Hives
How to use Flavetag 35mg Tablet SR:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take the Flavetag 35mg Sustained-Release tablet with food.
How Flavetag 35mg Tablet SR works:
The sustained-release Flavetag 35mg tablet is used to treat angina. It improves cardiac efficiency by altering myocardial metabolism, reducing the heart's reliance on fatty acids in favor of glucose for energy production.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Flavetag 35mg sustained-release tablets and alcohol may lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Flavetag 35mg sustained-release tablets in pregnancy is currently unavailable. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Flavetag 35mg sustained-release tablets and breastfeeding are currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Extended-release Flavetag 35mg tablets can cause drowsiness, blurred vision, and dizziness. Driving is discouraged if these side effects are experienced.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Flavetag 35mg SR tablets, as dose modification may be necessary. Consult a physician for guidance. Flavetag 35mg SR tablets are contraindicated in individuals with severe kidney disease.
LiverCONSULT YOUR DOCTOR
Data regarding the use of Flavetag 35mg sustained-release tablets in individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Flavetag 35mg Tablet SR :
Should you forget to take a Flavetag 35mg Tablet SR, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Flavetag 35mg Tablet SR
| Label | Value |
|---|---|
| Chemical Type | Benzylamines |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | Fatty acid and sodium channel modulator |
